Pharmaceuticals News
Source: Google
Pharmaceuticals News
ASCO26: Solid tumour data readouts outline
ASCO26: Solid tumour data readouts outline Merck & Co’s oncology prowess Pharmaceutical Technology
Posted on 4 June 2026 | 7:47 pm
Assessing Mirum Pharmaceuticals (MIRM)
Assessing Mirum Pharmaceuticals (MIRM) Valuation After Strong Long Term Gains And Recent Share Price Pullback simplywall.st
Posted on 4 June 2026 | 3:36 pm
Supreme Court Rules in Favor of Hikma
Supreme Court Rules in Favor of Hikma Pharmaceuticals in Patent Dispute geneonline.com
Posted on 4 June 2026 | 3:22 pm
Hikma comments on Supreme Court of the
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma PR Newswire
Posted on 4 June 2026 | 2:39 pm
Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein The National Law Review
Posted on 4 June 2026 | 2:29 pm
Source: Yahoo
Pharmaceuticals News
NRx Pharmaceuticals (NASDAQ: NRXP) closes
NRx Pharmaceuticals (NASDAQ: NRXP) closes $22.3M stock sale Stock Titan
Posted on 4 June 2026 | 2:20 pm
NRx Pharmaceuticals Closes $22.3 Million
NRx Pharmaceuticals Closes $22.3 Million Public Offering to Support Growth and Development of CNS Therapeutics Quiver Quantitative
Posted on 4 June 2026 | 2:20 pm
Eloxx Pharmaceuticals (ELOX) targets
Eloxx Pharmaceuticals (ELOX) targets $10–$12 offering and Nasdaq uplisting Stock Titan
Posted on 4 June 2026 | 2:17 pm
NRx Pharmaceuticals, Inc. Announces Closing
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 GlobeNewswire
Posted on 4 June 2026 | 2:12 pm
Biotech NRx raises $22.3M to fund working
Biotech NRx raises $22.3M to fund working capital and growth Stock Titan
Posted on 4 June 2026 | 2:12 pm
Source: Bing
Pharmaceuticals News
InMed Pharmaceuticals regains Nasdaq
InMed Pharmaceuticals regains Nasdaq compliance Investing.com
Posted on 4 June 2026 | 2:07 pm
Recursion (RXRX) director Bumpus sells 4,386
Recursion (RXRX) director Bumpus sells 4,386 shares under Rule 10b5-1 plan Stock Titan
Posted on 4 June 2026 | 2:04 pm
Recursion (NASDAQ: RXRX) director sells
Recursion (NASDAQ: RXRX) director sells 30,000 shares under 10b5-1 plan Stock Titan
Posted on 4 June 2026 | 2:04 pm
InMed Pharmaceuticals Regains Compliance
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements TMX Newsfile
Posted on 4 June 2026 | 2:00 pm
Vertex Pharmaceuticals Inc. stock
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains MarketWatch
Posted on 4 June 2026 | 1:38 pm